Drug & supplement interaction

M1-4add + Amivantamab-Vmjw

Amivantamab-Vmjw brand name: Rybrevant.

No Known Interaction
The bottom line No known interaction

We found no known interaction between M1-4add and Amivantamab-Vmjw in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first.

Know someone taking this? Share
Interaction report

M1-4add and Amivantamab-Vmjw

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between Amivantamab-Vmjw and M1-4add in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

Worth understanding: our licensed dataset holds no drug-interaction record for M1-4add at all — not against Amivantamab-Vmjw, and not against any other medication we track. This verdict therefore rests on the absence of any recorded data, not on research that looked at this combination and found nothing. We cannot rule an interaction out.

If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

M1-4add safety at a glance

M1-4add overall Not established This product cannot be identified, so its safety is unknown.
Pregnancy Possibly Unsafe When used orally. Prohormones can be converted to active hormones in the body and cause adverse effects such as menstrual irregularities, infertility, hair loss... Read the full pregnancy detail
Breastfeeding Possibly Unsafe When used orally. Prohormones can be converted to active hormones in the body and cause adverse effects such as menstrual irregularities, infertility, hair loss... Read the full breastfeeding detail

Pregnancy & breastfeeding ratings are from Natural Medicines (Therapeutic Research Center) — the full detail is in the Special populations card below. Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining Amivantamab-Vmjw and M1-4add? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
What to actually watch for

What Amivantamab-Vmjw’s Own FDA Label Lists

This is not an interaction — none of it involves M1-4add. These are the most notable effects listed in the ADVERSE REACTIONS section of Amivantamab-Vmjw’s own FDA label, for the medication by itself. Knowing the drug’s own list makes it easier to work out the likely cause if something new turns up while you take both. 10 of them are worth acting on rather than waiting out — marked below.

  • A stroke or mini-stroke Worth acting on
  • Muscle weakness Worth acting on
  • A heart attack Worth acting on
  • Blood clots Worth acting on
  • A severe skin reaction Worth acting on
  • A low platelet count Worth acting on
  • Kidney problems Worth acting on
  • Shortness of breath Worth acting on
  • A severe allergic reaction Worth acting on
  • A low white blood cell count Worth acting on

Showing the 10 most notable of 34 label-listed effects — ranked by how unusual each one is across medicines generally, with serious effects weighted up.

From the ADVERSE REACTIONS section of the FDA label for Amivantamab-Vmjw. Read the label on DailyMed › M1-4add’s licensed record lists no adverse effects our clinical vocabulary could match, so there is no M1-4add side to compare — that is a limit of the record, not a statement that M1-4add has no side effects.

Special populations

M1-4add in Pregnancy & Breastfeeding

Pregnancy And Lactation Possibly Unsafe

When used orally. Prohormones can be converted to active hormones in the body and cause adverse effects such as menstrual irregularities, infertility, hair loss, and acne. Prohormones have also been associated with hepatotoxicity and increased risk of cardiovascular disease. The U.S. Food and Drug Administration and other regulatory agencies warn that dietary supplements containing prohormones are dangerous. Avoid using.

DISCLAIMER: This tool is intended for informational purposes only, and should not be interpreted as specific medical advice. Patients should consult with a qualified healthcare provider before making decisions about therapies and/or health conditions.© 2026 Therapeutic Research Center

How much people look this up

Where M1-4add and Amivantamab-Vmjw Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement M1-4add
Steady interest

#1,033 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication Amivantamab-Vmjw
Top 25%

#619 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every M1-4add reference on this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified September 13, 2026. The M1-4add and Amivantamab-Vmjw records this page draws on were last updated June 22, 2026.
  • What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
Data structure & sourcing designed and verified by .
Supplement

About M1-4add

What is M1-4add?

"M1-4add" does not match any recognized dietary supplement, herb, or botanical that we can confidently identify. Because we cannot verify what this product is, we cannot describe its uses, safety, or dosing. Please check the product label and ingredient list, and talk with a pharmacist or doctor before using anything with this name.

An interaction check asks whether these two react with each other — it does not ask whether M1-4add is a good idea for someone in your situation. Here is what our M1-4add record says about it on its own.

M1-4add: dosing

There is no established or recognized dose for M1-4add because the product cannot be identified. Never assume a higher dose is safer or more effective.

From our M1-4add monograph — the full record covers uses, side effects and every documented interaction.

Read the full M1-4add monograph & all interactions
Medication

About Amivantamab-vmjw Injection

What Is Amivantamab-vmjw Injection Used For?

Brand name: Rybrevant

Rybrevant (amivantamab-vmjw) is used to treat adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) that carries specific changes (mutations) in the EGFR gene. The exact regimen depends on which mutation is present and whether prior treatment has been received.

Rybrevant is used: in combination with lazertinib as a first-line treatment for NSCLC with EGFR exon 19 deletions or exon 21 L858R mutations; in combination with carboplatin and pemetrexed for those same mutations when the cancer progressed after an EGFR tyrosine kinase inhibitor; in combination with carboplatin and pemetrexed as a first-line treatment for NSCLC with EGFR exon 20 insertion mutations; and as a single agent for NSCLC with exon 20 insertion mutations when the cancer progressed after platinum-based chemotherapy. In every case, patients must first be confirmed to carry the relevant mutation by an FDA-approved test.

See full Amivantamab-vmjw Injection drug information
Keep checking

Other Drugs & M1-4add

Browse every other medication we’ve checked against M1-4add — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
0Moderate
0Minor
2,829No known interaction
No interaction 2,829 drugs checked — show the list
Evidence & sources

M1-4add References

The 1 references that drive our M1-4add monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

  1. Joseph JF, Parr MK. Synthetic androgens as designer supplements. Curr Neuropharmacol. 2015;13(1):89-100. PubMed

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Taking M1-4add and Amivantamab-Vmjw Together: Common Questions

Is it safe to take M1-4add with Amivantamab-Vmjw?
We do not list a known interaction between M1-4add and Amivantamab-Vmjw. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Still Have a Question About Amivantamab-Vmjw and M1-4add?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.